The latest biotech news

gilead hiv aids grant retroviral truvada

News and Trends 23 Feb 2016

How could the HIV Field benefit from Gilead’s new €2M Research Grants?

The US Giant Gilead is opening a new program of Grants to fund the next generation of HIV research for 3-years. Targets are academic institutions and non-profit organization. HIV remains a global health challenge, with around 37 million people infected in the world. The rate of new infections fell in the last decades, but it is […]

February 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

desktop genetics gene ngs illumina epigenetics

News and Trends 23 Feb 2016

UK Start-Up Gets €380k to Understand Cancer with CRISPR

Desktop Genetics, a small bioinformatics start-up out of London, has won a substantial grant to understand why some cancer cells just won’t quit. To do this, it relies on CRISPR, their expertise with genetic data, and research from Imperial College London. Desktop Genetics has already proven that it can move some money, with a €1.87 […]

February 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

biotech nasdaq stock top biopharma finance 2016

News and Trends 23 Feb 2016

7 Trendy European Biotechs Listed on the NASDAQ in 2016

Here are 7 European Biotechs listed on the NASDAQ we thought were worth mentioning in more depth; location, market cap and brief financial and R&D backgrounds. NASDAQ is the second-largest Stock exchange in the world, based in New York, and the largest for high-tech companies. It seems to be the real test for a European biotech to […]

February 23, 2016 - 6 minutesmins - By Philip Hemme

paion surgery Remimazolam cardiac colonoscopy praion

News and Trends 22 Feb 2016

This German Biotech had to stop its EU Phase III Trial for Lack of Recruitment

The Aachen-based pharma Paion (Germany), has been forced to axe a European phase III trial for a Surgical sedative, after failing to recruit enough patients. The company will instead focus its efforts on its ongoing US trials. This is a blow to Paion’s pipeline, which is led by Remimazolam. The company stock price decreased almost 40%, but it […]

February 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

osteoporosis vertebral column denosumab amgen ucb

News and Trends 22 Feb 2016

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

UCB (Belgium) has a monoclonal antibody candidate (romozumab) which has met its primary endpoints for a phase III Osteoporosis trial, FRAME in partnership with Amgen. The drug showed 75% improvement (compared to placebo) and few side effects. UCB in Brussels is developing immunotherapies for a range of chronic diseases, which has now gotten good phase III results for an […]

February 22, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 22 Feb 2016

Making Bladder Cancer Cells Glow earns French Biotech €1.5M

VitaDX (France), is developing a non-invasive medical device for early detection of bladder cancer, based on a syndicate of French academic research. This simple urine sample analysis has attracted over €1.5M in preparation for clinical trials and a global market launch. The technology operated by VitaDX is the result of a research collaboration between the Institute of Molecular […]

February 22, 2016 - 3 minutesmins - By Dani Bancroft

onxeo cancer beleodaq interview Judith Greciet

News and Trends 22 Feb 2016

Meet the CEO of a Confident Orphan Oncology Biotech from France & Denmark

Last week, I was in Paris to meet with one of our Investors, during which time I also had a chance to visit the French Cancer Biotech, Onxeo. I met with the CEO of Onxeo, Judith Greciet, who was confident about the future of the company. She moved into the role in 2011 after having spent […]

February 22, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 19 Feb 2016

Biotech of the week: NZYTech, one of the biggest Portuguese Biotech companies

This week, we leave the cold of Norway and head South-West to warmer climates. Not Spain this time, we arrive in the capital of Portugal, Lisbon. This city has a nightlife that can rival Madrid, Castles looking onto beaches and is the location of our biotech of the week, NZYTech. City: Lisbon, Portugal Founded: 2008 Employees: 50 […]

February 19, 2016 - 1 minutemin - By Philip Hemme

bone therapeutics allob preob spine therapy medtech

News and Trends 18 Feb 2016

This Bone Cell Therapy Could Make it to a Shelf Near You

Bone Therapeutics (Belgium) is almost finished with the phase IIa trial for a Spinal cell therapy. The 12 people treated for degenerative bone conditions show no complications – a gold star for the safety check of this off-the-shelf product. This Belgian biotech is developing two different osteoblastic cell therapies, PREOB and ALLOB, to treat a variety of […]

February 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

jens nielsen novozymes chalmers nordisk novo cell factories

News and Trends 18 Feb 2016

This Pioneering Systems Biology Professor Received a €400K Prize from Novozymes

Jens Nielsen pioneered Systems Biology in Europe. His research efforts focus on transferring science research to industrial applications – to create a society independent of fossil fuels. He has now been awarded Novozymes Prize. Nielsen, a professor at Chalmers University of Technology in Gothenburg (Sweden), literally co-wrote the book on Metabolic Engineering back in 1998. During this period he […]

February 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

italy agriculture biotech fund crea cisgenesis gmo

News and Trends 18 Feb 2016

Italy Bets on Agriculture and Invests €21M in Sustainable-Biotech

Italian agriculture is booming with Innovation. To boost the creation of cutting-edge products and increase competition between businesses, €21M has been provided by the Italian government to fund sustainable biotechnology and research. The three-year plan focuses on the Council for Agricultural Research and Agricultural Economics Analysis (CREA), a specialized research centre in Rome which is collaborating with the […]

February 18, 2016 - 3 minutesmins - By Joachim Eeckhout

DIRK BUSCH TECHNICAL UNIVERSITY MUNICH car t leukemia all

News and Trends 17 Feb 2016

Cancer: World Best Ever CAR-T Results have Just been Disclosed

These are the best results yet for CAR-T, this time from a research group led by Dirk Busch at the Technical University of Munich (Germany). In part backed by Juno Therapeutics, a method to select more potent T-cells and engineer a safety mechanism was announced at the annual meeting of the AAAS in Washington (US). CAR-T therapies are one of the ways […]

February 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

How could the HIV Field benefit from Gilead’s new €2M Research Grants?

UK Start-Up Gets €380k to Understand Cancer with CRISPR

7 Trendy European Biotechs Listed on the NASDAQ in 2016

This German Biotech had to stop its EU Phase III Trial for Lack of Recruitment

Can this Positive Phase III Immunotherapy End Spinal Fractures due to Osteoporosis?

Making Bladder Cancer Cells Glow earns French Biotech €1.5M

Meet the CEO of a Confident Orphan Oncology Biotech from France & Denmark

Biotech of the week: NZYTech, one of the biggest Portuguese Biotech companies

This Bone Cell Therapy Could Make it to a Shelf Near You

This Pioneering Systems Biology Professor Received a €400K Prize from Novozymes

Italy Bets on Agriculture and Invests €21M in Sustainable-Biotech

Cancer: World Best Ever CAR-T Results have Just been Disclosed

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!